COMP <GO>
EZPW vs ARHS // EV/EBITDA & P/E VALUATION
EZCORP Inc. Class A Non Voting (NASDAQ) VS. Arhaus Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: EZPW 8
— ARHS 5
▲ EV/EBITDA & P/E VALUATION LEADER: ARHS
LAST: $29.11 (-1.99%) • MKT CAP: $1.79B
valuation
12.3x
LAST: $12.71 (+10.33%) • MKT CAP: $1.80B
valuation
10.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EZPW VS. ARHS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EZPW | ARHS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 58.50% | 38.90% | +19.60 | EZPW | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.50% | 42.60% | -32.10 | ARHS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.3x | 10.0x | +2.30 | ARHS | /valuation <GO> |
| Free Cash Flow Yield | 8.33% | 3.27% | +5.06 | EZPW | /fcf-yield <GO> |
| Operating Margin | 11.70% | 6.40% | +5.30 | EZPW | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 4.90% | +3.70 | EZPW | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 8.50% | +1.20 | EZPW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | ARHS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.10 | 2.66 | +0.44 | EZPW | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | EZPW | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.5 | 73.5 | -39.00 | ARHS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.2x | 24.9x | -9.70 | EZPW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.79B | $1.80B | -$13.0M | ARHS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EZPW REV | ARHS REV | EZPW GROSS % | ARHS GROSS % | EZPW FCF | ARHS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.27B | $1.38B | 58.5% | 38.9% | $149.0M | $59.0M |
| FY 2024 | $1.16B | $1.27B | 58.7% | 39.4% | $113.6M | $39.7M |
| FY 2023 | $1.05B | $1.29B | — | — | $101.8M | $168.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EZPW // BETA —
ARHS // BETA —